Novel inhibition of cis/trans retinoic acid interconversion in biological fluids -: an accurate method for determination of trans and 13-cis retinoic acid in biological fluids

被引:13
|
作者
Wang, CJ
Pao, LH
Hsiong, CH
Wu, CY
Whang-Peng, JJK
Hu, OYP
机构
[1] Natl Def Med Ctr, NeiHu, Taipei 11490, Taiwan
[2] Natl Hlth Res Inst, Canc Res Ctr, Taipei, Taiwan
[3] Natl Def Med Ctr, Pharmaceut Res Inst, Taipei 11490, Taiwan
[4] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan
关键词
interconversion; pharmacokinetics; retinoic acid;
D O I
10.1016/S1570-0232(03)00572-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0 ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25 degreesC were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150 muM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000 ng/ml) and 13-cRA (5-800 ng/ml) in plasma showed good linearity (r(2) = 0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000 ng/ml and 5 to 800 ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5 ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45 mg/m(2) per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条